Literature DB >> 22639356

Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.

Matthew D Thompson1, Daniel A Beard, Fan Wu.   

Abstract

Permeability-limited two-subcompartment and flow-limited, well-stirred tank tissue compartment models are routinely used in physiologically-based pharmacokinetic modeling. Here, the permeability-limited two-subcompartment model is used to derive a general flow-limited case of a two-subcompartment model with the well-stirred tank being a specific case where tissue fractional blood volume approaches zero. The general flow-limited two-subcompartment model provides a clear distinction between two partition coefficients typically used in PBPK: a biophysical partition coefficient and a well-stirred partition coefficient. Case studies using diazepam and cotinine demonstrate that, when the well-stirred tank is used with a priori predicted biophysical partition coefficients, simulations overestimate or underestimate total organ drug concentration relative to flow-limited two-subcompartment model behavior in tissues with higher fractional blood volumes. However, whole-body simulations show predicted drug concentrations in plasma and lower fractional blood volume tissues are relatively unaffected. These findings point to the importance of accurately determining tissue fractional blood volume for flow-limited PBPK modeling. Simulations using biophysical and well-stirred partition coefficients optimized with flow-limited two-subcompartment and well-stirred models, respectively, lead to nearly identical fits to tissue drug distribution data. Therefore, results of whole-body PBPK modeling with diazepam and cotinine indicate both flow-limited models are appropriate PBPK tissue models as long as the correct partition coefficient is used: the biophysical partition coefficient is for use with two-subcompartment models and the well-stirred partition coefficient is for use with the well-stirred tank model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639356      PMCID: PMC3400708          DOI: 10.1007/s10928-012-9252-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  29 in total

1.  Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.

Authors:  Patrick Poulin; Frank-Peter Theil
Journal:  J Pharm Sci       Date:  2002-05       Impact factor: 3.534

2.  Distribution of blood (Fe 59) and plasma (I 131) volumes of rats determined by liquid nitrogen freezing.

Authors:  N B EVERETT; B SIMMONS; E P LASHER
Journal:  Circ Res       Date:  1956-07       Impact factor: 17.367

3.  Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Susan Murby; Sophie Gisbert; Brent Collins; Kelly Dickens; Judith Duffy; Ziad Hussain; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

4.  Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS.

Authors:  Ivelina Gueorguieva; Leon Aarons; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-29       Impact factor: 2.745

5.  Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations.

Authors:  S P Khor; M Mayersohn
Journal:  Drug Metab Dispos       Date:  1991 Mar-Apr       Impact factor: 3.922

Review 6.  Cotinine as a biomarker of environmental tobacco smoke exposure.

Authors:  N L Benowitz
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

7.  Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.

Authors:  Y Igari; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

8.  Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model.

Authors:  Stephen J Godin; Michael J DeVito; Michael F Hughes; David G Ross; Edward J Scollon; James M Starr; R Woodrow Setzer; Rory B Conolly; Rogelio Tornero-Velez
Journal:  Toxicol Sci       Date:  2010-03-03       Impact factor: 4.849

9.  A physiologically based pharmacokinetic model for nicotine and cotinine in man.

Authors:  D E Robinson; N J Balter; S L Schwartz
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

10.  Constant-rate infusion of nicotine and cotinine. I. A physiological pharmacokinetic analysis of the cotinine disposition, and effects on clearance and distribution in the rat.

Authors:  J Gabrielsson; U Bondesson
Journal:  J Pharmacokinet Biopharm       Date:  1987-12
View more
  3 in total

1.  A simple physiologically based pharmacokinetic model evaluating the effect of anti-nicotine antibodies on nicotine disposition in the brains of rats and humans.

Authors:  Kyle Saylor; Chenming Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2016-07-26       Impact factor: 4.219

2.  Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.

Authors:  Robert G Pearce; R Woodrow Setzer; Jimena L Davis; John F Wambaugh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-10-14       Impact factor: 2.745

3.  Intranasal Coadministration of a Diazepam Prodrug with a Converting Enzyme Results in Rapid Absorption of Diazepam in Rats.

Authors:  Davin Rautiola; Patricia D Maglalang; Narsihmulu Cheryala; Kathryn M Nelson; Gunda I Georg; Jared M Fine; Aleta L Svitak; Katherine A Faltesek; Leah R Hanson; Usha Mishra; Lisa D Coles; James C Cloyd; Ronald A Siegel
Journal:  J Pharmacol Exp Ther       Date:  2019-03-05       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.